Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-06

Robert H. Heflich

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

High Impact

Role not yet determined Is this you? Add your title

Also affiliated: United States Food and Drug Administration (1982–2026); Center for Drug Evaluation and Research (2009); University of Utah (1991); The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (1986); Letterman Army Medical Center (1973); Instituto Superior Técnico (2005); The Ohio State University (1986); Michigan State University (1977–1980)

52 h-index 295 pubs 8,856 cited

  • Animals
  • Mutagens
  • Mutation
  • Mutagenicity Tests
  • Rats
  • Male
  • Humans
  • Mice
  • Hypoxanthine Phosphoribosyltransferase
  • Female
  • DNA Damage
  • Carcinogens
  • Salmonella typhimurium
  • Cricetinae
  • DNA

Biography and Research Information

OverviewAI-generated summary

Robert H. Heflich's research focuses on genetic toxicology and the assessment of mutagenicity and carcinogenicity of various chemical agents. His work has investigated the mechanisms by which environmental mutagens interact with DNA, leading to adduct formation and subsequent mutations. This includes studies on arylamines and nitroarenes, examining their metabolic activation and their role in bacterial mutagenesis and mammalian carcinogenesis, particularly in the urinary bladder.

Dr. Heflich has contributed to the development and application of various genotoxicity assays, including the Ames test and in vivo transgenic mutation assays like the Pig-a assay. His research also extends to evaluating the genotoxicity of emerging materials, such as silver nanoparticles. Furthermore, his work has explored the derivation of point of departure (PoD) estimates from genetic toxicology studies for their application in risk assessment. He has maintained an active research group and collaborated extensively with colleagues at the National Center for Toxicological Research, including Nan Mei, Ji‐Eun Seo, Xiaoqing Guo, and Xilin Li.

With a h-index of 52 and over 8,800 citations from nearly 300 publications, Dr. Heflich is recognized as a highly cited researcher. His work spans several decades, demonstrating a sustained contribution to the field of toxicology and mutagenesis.

Metrics

  • h-index: 52
  • Publications: 295
  • Citations: 8,856

Selected Publications

  • Adjusting the Preincubation Conditions to Enhance the Ames Test for Detecting the Mutagenicity of <i>N</i> ‐Nitrosamines (2026)
  • Mutagenicity of EAT-positive NDSRIs in HepaRG spheroids (2026)
  • Comparative genotoxicity assessment of ortho-phthalaldehyde using human in vitro organotypic airway epithelial cultures and standard in vitro genotoxicity assays (2026)
  • Mutagenicity of <i>N</i> -nitroso-fluoxetine and <i>N</i> -nitroso-varenicline in human HepaRG cell models (2026)
    1 citation DOI OpenAlex
  • Nitrosamine Ames Data Review and Method Development: proceedings of a US FDA/HESI workshop (2026)
  • Detection of In Vivo Mutation in the Hprt and Pig-a Genes of Rat Lymphocytes (2025)
  • Mutation accumulation following extended exposure of human HepaRG cells to a genotoxic carcinogen (2025)
  • Genotoxicity evaluation of ten nitrosamine drug substance-related impurities using 2D and 3D HepaRG cell models (2025)
    Regulatory Toxicology and Pharmacology 12 citations DOI OpenAlex
  • N-nitroso-ethylisopropylamine mutagenicity in rat liver using the cII transgenic mutation assay and duplex sequencing analysis of genomic DNA (2025)
    1 citation DOI OpenAlex
  • Comparative DNA damage induced by eight nitrosamines in primary human and macaque hepatocytes (2025)
    2 citations DOI OpenAlex
  • HESI GTTC ring trial: Concordance between Ames and rodent carcinogenicity outcomes for N-nitrosamines (NAs) with rat and hamster metabolic conditions (2025)
    Regulatory Toxicology and Pharmacology 14 citations DOI OpenAlex
  • Characterizing the Pulmonary Toxicity and Potential Mutagenicity of Formaldehyde Fumes in a Human Bronchial Epithelial Tissue Model (2025)
    1 citation DOI OpenAlex
  • Integration of the rat liver micronucleus assay into a 28-day treatment protocol: testing the genotoxicity of 4 small-molecule nitrosamines with different carcinogenic potencies and tumor target specificities (2025)
    1 citation DOI OpenAlex
  • Mutagenicity and genotoxicity evaluation of 15 nitrosamine drug substance-related impurities in human TK6 cells (2024)
    Regulatory Toxicology and Pharmacology 17 citations DOI OpenAlex
  • Optimizing the detection of N-nitrosamine mutagenicity in the Ames test (2024)
    Regulatory Toxicology and Pharmacology 32 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

501 Collaborators 139 Institutions 21 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics